PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
26-Nov-2024 Basketball Star PJ Hall Signs on as sam(R) Brand Ambassador AccessWire
26-Nov-2024 Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs AccessWire
26-Nov-2024 Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation AccessWire
26-Nov-2024 Unlocking the Mysteries of Consciousness: SIDHE Announces Revolutionary Research Pathways and Transformative Programs AccessWire
26-Nov-2024 Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR Trial AccessWire
26-Nov-2024 Dr. Alisa Yamasaki Featured in Princeton Health Magazine Discussing Advanced Treatments for Bell's Palsy to Restore Facial Symmetry AccessWire
26-Nov-2024 The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time AccessWire
26-Nov-2024 Gold Biotechnology Enhances Visibility and Engagement Through Bioz Partnership AccessWire
25-Nov-2024 Justera Health Revises Vesting Schedule of RSU Grant AccessWire
25-Nov-2024 Medicure Reports Financial Results For Quarter Ended September 30, 2024 AccessWire
25-Nov-2024 Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment AccessWire
25-Nov-2024 Juva Life Inc. Updates Shareholders on Court-Appointed Receivership Proceedings AccessWire
25-Nov-2024 Ankle & Foot Centers of America Highlights Vital Role of Podiatric Care for People with Diabetes AccessWire
25-Nov-2024 Wellstack Partners With Hartford HealthCare to Advance Data Integration and Healthcare Analytics AccessWire
25-Nov-2024 Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference AccessWire
25-Nov-2024 CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy AccessWire
25-Nov-2024 MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences AccessWire
25-Nov-2024 Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled AccessWire
25-Nov-2024 Neurotech Innovator UNEEG Medical Receives FDA Breakthrough Device Designation Within Monitoring and Diagnostic of Epilepsy AccessWire
25-Nov-2024 TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update AccessWire